病例报告

原发性醛固酮增多症肾上腺切除术后慢性肾功能不全1例

  • 安文成 ,
  • 闫慧娴 ,
  • 邓正照 ,
  • 陈芳 ,
  • 欧小虹 ,
  • 金红心 ,
  • 黄薇
展开
  • 1.北京市海淀医院,北京大学第三医院海淀院区内分泌科,北京 100080
    2.北京大学第三医院内分泌科,北京 100191

收稿日期: 2019-12-23

  网络出版日期: 2021-12-13

Chronic kidney disease after adrenalectomy in a patient with primary aldosteronism

  • Wen-cheng AN ,
  • Hui-xian YAN ,
  • Zheng-zhao DENG ,
  • Fang CHEN ,
  • Xiao-hong OU ,
  • Hong-xin JIN ,
  • Wei HUANG
Expand
  • 1. Department of Endocrinology, Beijing Haidian Hospital, Peking University Third Hospital (Haidian District), Beijing 100080, China
    2. Department of Endocrinology, Peking University Third Hospital, Beijing 100191, China

Received date: 2019-12-23

  Online published: 2021-12-13

本文引用格式

安文成 , 闫慧娴 , 邓正照 , 陈芳 , 欧小虹 , 金红心 , 黄薇 . 原发性醛固酮增多症肾上腺切除术后慢性肾功能不全1例[J]. 北京大学学报(医学版), 2021 , 53(6) : 1201 -1204 . DOI: 10.19723/j.issn.1671-167X.2021.06.033

Abstract

We report one case of estimated glomerular filtration rate (eGFR) decline after taking unilateral adrenalectomy due to aldosterone adenoma. A 60-year-old male with 23-year history of hypertension was reported to the endocrinologist due to hypokalemia (serum potassium 3.01 mmol/L). Urine microalbumin / creatinine (ALB/CR) was 70.15 mg/g, serum creatinine was 82 μmol/L and eGFR was 89.79 mL/(min·1.73 m 2). Random serum aldosterone was 172.2-203.5 ng/L, and random plasma rennin activity was 0-0.17 μg/(L·h). His captopril challenge test suggested that his aldosterone le-vels were suppressed by 8% (<30%) and the adrenal enhanced computed tomography scan revealed a left adrenal tumor. The patient was diagnosed with primary hyperaldosteronism (PA), aldosterone adenoma and underwent left laparoscopic adrenalectomy. Histological examination confirmed adrenal cortical adenoma. One week after the operation, his serum creatinine was increased to 127 μmol/L compared with preoperative level; eGFR was 32.34 mL/(min·1.73 m 2). His systolic blood pressure (SBP) was 110 mmHg and diastolic blood pressure (DBP) was 60 mmHg (hypotensive drugs discontinued), and serum potassium level was 5.22 mmol/L. At the end of the 2-year follow up, the serum creatinine of this patient remained at 109-158 μmol/L and eGFR fluctuated from 63.28-40.12 mL/(min·1.73 m 2). PA is one of the most common causes of secondary hypertension. Several studies have reported renal function deterioration of PA patients after unilateral adrenalectomy, like the patient in this article. Age, preoperative plasma aldosterone concentration, albuminuria and preoperative potassium level might be significant predictors of a decrease in the eGFR. Growing evidence suggests that aldosterone could contribute to structural kidney damage, arterial injury and hemodynamic disorder. At the same time, patients with PA exhibit glomerular hyperfiltration and glomerular vascular hypertension, leading to the misinterpretation of renal function in PA patients as subtle kidney damage may be masked by the glomerular hyperfiltration before treatment. After a unilateral adrenalectomy, glomerular hyperfiltration by aldosterone excess is resolved and renal damage can be unmasked. In conclusion, kidney function deterioration after adrenalectomy can be detected in some patients with PA. Thus, accurate evaluation of kidney function in patients with PA may be essential, especially for those with preoperative risk factors for postoperative renal impairment. After unilateral adrenalectomy, close monitoring of renal function and adequate management are required for PA patients.

参考文献

[1] Hundemer GL, Curhan GC, Yozamp N, et al. Renal outcomes in medically and surgically treated primary aldosteronism[J]. Hypertension, 2018, 72(3):658-666.
[2] Park KS, Kim JH, Yang YS, et al. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism[J]. Endocr J, 2017, 64(6):623-632.
[3] Kanarek-Kucner J, Stefanski A, Barraclough R, et al. Insufficiency of the zona glomerulosa of the adrenal cortex and progressive kidney insufficiency following unilateral adrenalectomy: Case report and discussion[J]. Blood Press, 2018, 27(5):304-312.
[4] Utsumi T, Kawamura K, Imamoto T, et al. Preoperative masked renal damage in Japanese patients with primary aldosteronism: Identification of predictors for chronic kidney disease manifested after adrenalectomy[J]. Int J Urol, 2013, 20(7):685-691.
[5] Iwakura Y, Morimoto R, Kudo M, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases[J]. J Clin Endocrinol Metab, 2014, 99(5):1593-1598.
[6] Sechi LA, Di Fabio A, Bazzocchi M, et al. Intrarenal hemodynamics in primary aldosteronism before and after treatment[J]. J Clin Endocrinol Metab, 2009, 94(4):1191-1197.
[7] Onohara T, Takagi T, Yoshida K, et al. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism[J]. Int J Urol, 2019, 26(2):229-233.
[8] Park SM, Jung WJ, Park JM, et al. Unmasked chronic renal function deterioration after unilateral adrenalectomy in patients with primary aldosteronism[J]. Kidney Res Clin Pract, 2016, 35(4):255-258.
[9] Hollenberg NK. Aldosterone in the development and progression of renal injury[J]. Kidney Int, 2004, 66(1):1-9.
[10] Briet M, Schiffrin EL. Aldosterone: Effects on the kidney and cardiovascular system[J]. Nat Rev Nephrol, 2010, 6(5):261-273.
[11] Sechi LA, Novello M, Lapenna R, et al. Long-term renal outcomes in patients with primary aldosteronism[J]. JAMA, 2006, 295(22):2638-2645.
文章导航

/